Predict your next investment

X-Cor Therapeutics company logo
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices

See what CB Insights has to offer

Founded Year



Seed VC | Alive

Total Raised


Last Raised

$2.6M | 1 yr ago

About X-Cor Therapeutics

X-Cor Therapeutics develops advanced medical devices, specializing in dialysis-like carbon dioxide removal systems.

X-Cor Therapeutics Headquarter Location

127 Western Ave

Boston, Massachusetts, 02134,

United States

Latest X-Cor Therapeutics News

X-Cor Therapeutics Closes $2.6M Funding Round

Nov 12, 2020

X-COR Therapeutics , an Allston, MA-based developer of a novel extracorporeal carbon dioxide removal device, closed a $2.6M seed financing. Alira Health’s investment arm, Alira Health Ventures, led the financing with syndication from Good Growth Capital, PiSA Biopharm, Flybridge Partners’ Graduate Syndicate, and other notable angel investors. The company intends to use the funds to continue developing its device toward clinical trials. Led by Jayon Wang, CEO, X-COR is a medical device company creating a carbon dioxide removal device that uses ultra-low-blood flows for the treatment for acute respiratory failure. Its novel technology is a patent-pending medical device and accompanying control algorithm that enables physicians to directly remove excess carbon dioxide from lung failure patients. FinSMEs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing X-Cor Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

X-Cor Therapeutics is included in 1 Expert Collection, including Medical Devices.


Medical Devices

7,891 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

X-Cor Therapeutics Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

X-Cor Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.